GLENMARK PHARMACEUTICALS
Back to Income Statement
|
GLENMARK PHARMACEUTICALS Last 5 Year Appropriations History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Appropriations | ₹7,955 Cr | ₹9,508 Cr | ₹8,175 Cr | ₹7,300 Cr | ₹6,391 Cr |
What is the latest Appropriations of GLENMARK PHARMACEUTICALS ?
| Year | Appropriations |
|---|---|
| Mar2025 | ₹7,955 Cr |
| Mar2024 | ₹9,508 Cr |
| Mar2023 | ₹8,175 Cr |
| Mar2022 | ₹7,300 Cr |
| Mar2021 | ₹6,391 Cr |
How is Appropriations of GLENMARK PHARMACEUTICALS Trending?
| Years | Appropriations | % Change | |
|---|---|---|---|
| Mar2025 | ₹7,955 Cr | -16.33 | |
| Mar2024 | ₹9,508 Cr | 16.30 | |
| Mar2023 | ₹8,175 Cr | 12.00 | |
| Mar2022 | ₹7,300 Cr | 14.22 | |
| Mar2021 | ₹6,391 Cr | - | |
Compare Appropriations of peers of GLENMARK PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLENMARK PHARMACEUTICALS | ₹63,874.6 Cr | 4.9% | 4.5% | 29.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,593.0 Cr | 2% | 6.7% | 14.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,737.0 Cr | 3.5% | 2.2% | 0.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹164,290.0 Cr | 4.6% | 9.9% | 41.5% | Stock Analytics | |
| CIPLA | ₹117,327.0 Cr | -0.3% | 3.7% | -2.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹112,994.0 Cr | 1.1% | 5.9% | 6.6% | Stock Analytics | |
GLENMARK PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLENMARK PHARMACEUTICALS | 4.9% |
4.5% |
29.5% |
| SENSEX | 2.2% |
5.1% |
-7% |
You may also like the below Video Courses